These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26866496)

  • 1. Botulinum Toxin Treatment of Cervical Dystonia.
    Bledsoe IO; Comella CL
    Semin Neurol; 2016 Feb; 36(1):47-53. PubMed ID: 26866496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
    Figgitt DP; Noble S
    Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia.
    Comella CL; Jankovic J; Shannon KM; Tsui J; Swenson M; Leurgans S; Fan W;
    Neurology; 2005 Nov; 65(9):1423-9. PubMed ID: 16275831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of cervical dystonia with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice.
    Jochim A; Meindl T; Mantel T; Zwirner S; Zech M; Castrop F; Haslinger B
    J Neurol; 2019 Aug; 266(8):1879-1886. PubMed ID: 31049731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE).
    Jankovic J; Adler CH; Charles D; Comella C; Stacy M; Schwartz M; Manack Adams A; Brin MF
    J Neurol Sci; 2015 Feb; 349(1-2):84-93. PubMed ID: 25595221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm.
    Med Lett Drugs Ther; 2010 Nov; 52(1351):90-1. PubMed ID: 21068703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and tolerability of botulinum toxins for the treatment of cervical dystonia.
    Brashear A
    Expert Opin Drug Saf; 2005 Mar; 4(2):241-9. PubMed ID: 15794717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.
    Poewe W; Burbaud P; Castelnovo G; Jost WH; Ceballos-Baumann AO; Banach M; Potulska-Chromik A; Ferreira JJ; Bihari K; Ehler E; Bares M; Dzyak LA; Belova AN; Pham E; Liu WJ; Picaut P
    Mov Disord; 2016 Nov; 31(11):1649-1657. PubMed ID: 27653448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical dystonia: improved treatment response to botulinum toxin after referral to a tertiary centre and the use of polymyography.
    Nijmeijer SW; Koelman JH; Standaar TS; Postma M; Tijssen MA
    Parkinsonism Relat Disord; 2013 May; 19(5):533-8. PubMed ID: 23466060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMG coherence and spectral analysis in cervical dystonia: discriminative tools to identify dystonic muscles?
    Nijmeijer SW; de Bruijn E; Forbes PA; Kamphuis DJ; Happee R; Koelman JH; Tijssen MA
    J Neurol Sci; 2014 Dec; 347(1-2):167-73. PubMed ID: 25305713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-utility analysis of two formulations of botulinum toxin type A in the treatment of blepharospasm and cervical dystonia in Spain].
    Sanz-Granda A; Marti MJ; Catalan MJ
    Rev Neurol; 2018 Dec; 67(12):465-472. PubMed ID: 30536360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cervical dystonia with botulinum toxins.
    Comella CL; Thompson PD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():16-20. PubMed ID: 16417593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and long-term efficacy of botulinum toxin type B in the treatment of cervical dystonia: report of 4 prospective, multicenter trials.
    Chinnapongse RB; Lew MF; Ferreira JJ; Gullo KL; Nemeth PR; Zhang Y
    Clin Neuropharmacol; 2012; 35(5):215-23. PubMed ID: 22932474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction.
    Lew MF
    Clin J Pain; 2002; 18(6 Suppl):S142-6. PubMed ID: 12569961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The setting of a botulinum toxin treatment service.
    Cavallini M
    Neurol Sci; 2014 May; 35 Suppl 1():49-50. PubMed ID: 24867836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal.
    Marsili L; Bologna M; Jankovic J; Colosimo C
    Expert Opin Drug Saf; 2021 Jun; 20(6):695-705. PubMed ID: 33831328
    [No Abstract]   [Full Text] [Related]  

  • 18. Botulinum Injections for Idiopathic Cervical Dystonia: a Longitudinal Study.
    Yahalom G; Fay-Karmon T; Livneh V; Israeli-Korn S; Ephraty L; Hassin-Baer S
    Neurotox Res; 2021 Aug; 39(4):1352-1359. PubMed ID: 34050898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
    Kaufman DM
    J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.